Mibolerone

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Mibolerone

Clinical data
Routes of administration	Oral
Legal status
Legal status	Schedule 3 (US)
Pharmacokinetic data
Metabolism	Hepatic
Elimination half-life	2-4 hours
Identifiers
IUPAC name (7R,8R,9S,10R,13S,14S,17S)-17-hydroxy- 7,13,17-trimethyl-1,2,6,7,8,9,10,11,1 2,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
CAS Number	3704-09-4
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C20H30O2
Molar mass	302.4558 g/mol

WikiDoc Resources for Mibolerone
Articles
Most recent articles on Mibolerone Most cited articles on Mibolerone Review articles on Mibolerone Articles on Mibolerone in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Mibolerone Images of Mibolerone Photos of Mibolerone Podcasts & MP3s on Mibolerone Videos on Mibolerone
Evidence Based Medicine
Cochrane Collaboration on Mibolerone Bandolier on Mibolerone TRIP on Mibolerone
Clinical Trials
Ongoing Trials on Mibolerone at Clinical Trials.gov Trial results on Mibolerone Clinical Trials on Mibolerone at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Mibolerone NICE Guidance on Mibolerone NHS PRODIGY Guidance FDA on Mibolerone CDC on Mibolerone
Books
Books on Mibolerone
News
Mibolerone in the news Be alerted to news on Mibolerone News trends on Mibolerone
Commentary
Blogs on Mibolerone
Definitions
Definitions of Mibolerone
Patient Resources / Community
Patient resources on Mibolerone Discussion groups on Mibolerone Patient Handouts on Mibolerone Directions to Hospitals Treating Mibolerone Risk calculators and risk factors for Mibolerone
Healthcare Provider Resources
Symptoms of Mibolerone Causes & Risk Factors for Mibolerone Diagnostic studies for Mibolerone Treatment of Mibolerone
Continuing Medical Education (CME)
CME Programs on Mibolerone
International
Mibolerone en Espanol Mibolerone en Francais
Business
Mibolerone in the Marketplace Patents on Mibolerone
Experimental / Informatics
List of terms related to Mibolerone

Mibolerone is an Anabolic steroid which is very androgenic. Orally administered, it is about 5 times more potent than testosterone as an anabolic agent and about 2.5 times more potent as an androgenic agent. It is one of the most androgenic agents in existence and as an effect often causes progesterone related gynecomastia.

References

Template:WikiDoc Sources